Key facts
- This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Feb 2024, 20:06.
J. E. Davis - 14 Feb 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- DGX
- Reported as of
- 14 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2024, 20:06:07 UTC
- Prior SEC filing
- 08 Mar 2023
- Next SEC filing
- 23 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for James E. Davis
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 16 Feb 2024.
Change
- Previous filing in this sequence was filed on 08 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +22,251
- Change %
- +22%
- Price
- $0.000000
- Shares after
- 124,885
- Date
- 14 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DGX
transaction
Derivative
Non-Qualifed Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +92,779
- Change %
- Price
- $0.000000
- Shares after
- 92,779
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 92,779
- Exercise price
- $127.80
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents an award of restricted share units.
Footnote F2
The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.